Portfolio of Gene Therapy Stocks

Here are 9 gene therapy stocks. See 10 Most Promising Gene Therapy Companies to Watch.

9 Portfolio of Gene Therapy Stocks

Name & Return

Symbol
& Snapshot

Akouos AKUS
Beam Therapeutics BEAM
bluebird bio BLUE
Crispr Therapeutics CRSP
Editas Medicine EDIT
Intellia Therapeutics NTLA
Krystal Biotech KRYS
uniQure N.V. QURE
Verve Therapeutics VERV
Display Price Chart for each stock.
Display Dividend Chart for each stock.

Portfolio Values

To inspect the performance of the Portfolio of Gene Therapy Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 5 stocks included in the portfolio computations are: BLUE, CRSP, EDIT, NTLA and QURE. The current value of the portfolio assumes that $2,000.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 4 stocks excluded from the portfolio computations because of insufficient price data are: AKUS, BEAM, KRYS and VERV.

The current value of the $10,000 investment is $8,842. The percent return is -11.58%. The annualized return is -2.43%.



Portfolio Value Chart for Last 100 Daily Closes



Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Gene Editing (CRISPR) Stocks

Portfolio of Genetic Testing Stocks

Portfolio of Genomics Stocks

Portfolio of Stem Cell Stocks